Incidence Of Neutropenia In Patients Receiving Either Nab-Paclitaxel Plus Gemcitabine Or Folfirinox As First-Line Treatment For Metastatic Pancreatic Adenocarcinoma
May 1, 2016, 00:00
10.1016/j.jval.2016.03.2005
https://www.valueinhealthjournal.com/article/S1098-3015(16)30293-5/fulltext
Title :
Incidence Of Neutropenia In Patients Receiving Either Nab-Paclitaxel Plus Gemcitabine Or Folfirinox As First-Line Treatment For Metastatic Pancreatic Adenocarcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30293-5&doi=10.1016/j.jval.2016.03.2005
First page :
A141
Section Title :
Cancer - Clinical Outcomes Studies
Open access? :
No
Section Order :
258